Vericel (VCEL) EPS (Weighted Average and Diluted) (2018 - 2025)
Historic EPS (Weighted Average and Diluted) for Vericel (VCEL) over the last 11 years, with Q3 2025 value amounting to $0.1.
- Vericel's EPS (Weighted Average and Diluted) rose 60000.0% to $0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.25, marking a year-over-year increase of 25714.29%. This contributed to the annual value of $0.2 for FY2024, which is 38643.85% up from last year.
- Per Vericel's latest filing, its EPS (Weighted Average and Diluted) stood at $0.1 for Q3 2025, which was up 60000.0% from -$0.01 recorded in Q2 2025.
- In the past 5 years, Vericel's EPS (Weighted Average and Diluted) registered a high of $0.38 during Q4 2024, and its lowest value of -$0.23 during Q1 2025.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.03, with a median of -$0.08 in 2021.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 23750.0% in 2021, then surged by 60000.0% in 2025.
- Vericel's EPS (Weighted Average and Diluted) (Quarter) stood at $0.1 in 2021, then rose by 30.0% to $0.13 in 2022, then skyrocketed by 107.69% to $0.27 in 2023, then surged by 41.95% to $0.38 in 2024, then crashed by 73.91% to $0.1 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.1 for Q3 2025, versus -$0.01 for Q2 2025 and -$0.23 for Q1 2025.